176 related articles for article (PubMed ID: 24520673)
1. [Correlation of androgen receptor CAG repeats with the risks of benign prostatic hyperplasia and prostate cancer: a meta-analysis].
Wang XM; Sun L; Zhang Z; Shi XH; Zhang YG; Wei D; Wan B; Yang Z; Wang JY
Zhonghua Nan Ke Xue; 2014 Feb; 20(2):172-6. PubMed ID: 24520673
[TBL] [Abstract][Full Text] [Related]
2. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?
Mishra D; Thangaraj K; Mandhani A; Kumar A; Mittal R
Clin Genet; 2005 Jul; 68(1):55-60. PubMed ID: 15952987
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor CAG polymorphism and prostate cancer risk.
Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growth.
Mitsumori K; Terai A; Oka H; Segawa T; Ogura K; Yoshida O; Ogawa O
Prostate; 1999 Dec; 41(4):253-7. PubMed ID: 10544298
[TBL] [Abstract][Full Text] [Related]
5. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor GGC polymorphism and testosterone levels associated with high risk of prostate cancer and benign prostatic hyperplasia.
Biolchi V; Silva Neto B; Pianta DB; Koff WJ; Berger M; Brum IS
Mol Biol Rep; 2013 Mar; 40(3):2749-56. PubMed ID: 23184046
[TBL] [Abstract][Full Text] [Related]
7. Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene.
Li C; Grönberg H; Matsuyama H; Weber G; Nordenskjöld M; Naito K; Bergh A; Bergerheim U; Damber JE; Larsson C; Ekman P
Int J Mol Med; 2003 Apr; 11(4):529-33. PubMed ID: 12632109
[TBL] [Abstract][Full Text] [Related]
8. Association of androgen receptor, prostate-specific antigen, and CYP19 gene polymorphisms with prostate carcinoma and benign prostatic hyperplasia in a north Indian population.
Soni A; Bansal A; Mishra AK; Batra J; Singh LC; Chakraborty A; Yadav DS; Mohanty NK; Saxena S
Genet Test Mol Biomarkers; 2012 Aug; 16(8):835-40. PubMed ID: 22731640
[TBL] [Abstract][Full Text] [Related]
9. Length and somatic mosaicism of CAG and GGN repeats in the androgen receptor gene and the risk of prostate cancer in men with benign prostatic hyperplasia.
Tayeb MT; Clark C; Murray GI; Sharp L; Haites NE; McLeod HL
Ann Saudi Med; 2004; 24(1):21-6. PubMed ID: 15310009
[TBL] [Abstract][Full Text] [Related]
10. CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians.
Giovannucci E; Stampfer MJ; Chan A; Krithivas K; Gann PH; Hennekens CH; Kantoff PW
Prostate; 1999 May; 39(2):130-4. PubMed ID: 10221569
[TBL] [Abstract][Full Text] [Related]
11. Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer.
Das K; Cheah PY; Lim PL; Zain YB; Stephanie FC; Zhao Y; Cheng C; Lau W
Cancer Lett; 2008 Sep; 268(2):340-7. PubMed ID: 18495332
[TBL] [Abstract][Full Text] [Related]
12. In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors.
Tsujimoto Y; Takakuwa T; Takayama H; Nishimura K; Okuyama A; Aozasa K; Nonomura N
Prostate; 2004 Feb; 58(3):283-90. PubMed ID: 14743468
[TBL] [Abstract][Full Text] [Related]
13. The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia.
Giovannucci E; Platz EA; Stampfer MJ; Chan A; Krithivas K; Kawachi I; Willett WC; Kantoff PW
Urology; 1999 Jan; 53(1):121-5. PubMed ID: 9886600
[TBL] [Abstract][Full Text] [Related]
14. Variation in CAG and GGN repeat lengths and CAG/GGN haplotype in androgen receptor gene polymorphism and prostate carcinoma in Nigerians.
Akinloye O; Gromoll J; Simoni M
Br J Biomed Sci; 2011; 68(3):138-42. PubMed ID: 21950206
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor gene polymorphism and prostate cancer in Taiwan.
Huang SP; Chou YH; Chang WS; Wu MT; Yu CC; Wu T; Lee YH; Huang JK; Wu WJ; Huang CH
J Formos Med Assoc; 2003 Oct; 102(10):680-6. PubMed ID: 14691592
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer.
Tan JSJ; Ong KC; Ong DBL; Wu YS; Razack A; Kuppusamy S; Lim J; Rhodes A
Malays J Pathol; 2019 Dec; 41(3):243-251. PubMed ID: 31901908
[TBL] [Abstract][Full Text] [Related]
17. South Indian men with reduced CAG repeat length in the androgen receptor gene have an increased risk of prostate cancer.
Krishnaswamy V; Kumarasamy T; Venkatesan V; Shroff S; Jayanth VR; Paul SFD
J Hum Genet; 2006; 51(3):254-257. PubMed ID: 16437189
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor CAG repeat length contraction in diseased and non-diseased prostatic tissues.
Sircar K; Gottlieb B; Alvarado C; Aprikian A; Beitel LK; Alam-Fahmy M; Begin L; Trifiro M
Prostate Cancer Prostatic Dis; 2007; 10(4):360-8. PubMed ID: 17440439
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effects of androgen receptor gene trinucleotide repeats and prostate-specific antigen gene polymorphisms on prostate cancer.
Alptekin D; Izmirli M; Bayazit Y; Luleyap HU; Yilmaz MB; Soyupak B; Erkoc MA; Tansug Z
Genet Mol Res; 2012 May; 11(2):1424-32. PubMed ID: 22653589
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of the androgen receptor gene is correlated with CAG polymorphic repeats in patients with prostate cancer.
Arredondo MI; Quintana JR; Meraz EA; HernáNdez FB; Ortega FL; Camberos AM; Arrazola MÁ; MartíNez ER; Prieto DC; Gutiérrez JC; Magallanes NG
J Genet; 2023; 102():. PubMed ID: 36988133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
